Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

David Planchard, Tae Min Kim, Julien Mazières, +16

The Lancet Oncology

OncologyNon-small-cell Lung CancerPathologyBronchial NeoplasmImmune Checkpoint Inhibitor +5

An EMT‐related gene signature for the prognosis of human bladder cancer

Rui Cao, Lushun Yuan, Bo Ma, +3

Journal of Cellular and Molecular Medicine

Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436)

Katherine L. Nathanson, Anne‐Marie Martin, Bradley Wubbenhorst, +17

Clinical Cancer Research

Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi

Bo Ma, Bea Christen, Danny T. M. Leung, +1

Journal of Clinical Microbiology

Parasitic DiseaseAllergyAutoimmune DiseaseHuman Serum SamplesImmunodeficiencies +13

Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC)

Rui Cao, Lushun Yuan, Bo Ma, +2

Cancer Immunology Immunotherapy

Immunotherapy ResponseUrologyTumor ImmunologyCancer ImmunosurveillanceGenitourinary Cancer +7

Interim results of phase II study BRF113928 of dabrafenib in <i>BRAF</i> V600E mutation–positive non-small cell lung cancer (NSCLC) patients.

David Planchard, Julien Mazières, Gregory J. Riely, +12

Journal of Clinical Oncology

Cancer ManagementPathologyTumor BiologyOncologyCancer Cell Biology +15

Statins attenuate outgrowth of breast cancer metastases

Colin H. Beckwitt, Amanda M. Clark, Bo Ma, +3

British Journal of Cancer

Phase 1 study of the BRAF inhibitor dabrafenib (D) with or without the MEK inhibitor trametinib (T) in combination with ipilimumab (Ipi) for V600E/K mutation–positive unresectable or metastatic melanoma (MM).

Igor Puzanov, Margaret K. Callahan, Gerald P. Linette, +11

Journal of Clinical Oncology

ImmunodeficienciesImmunologyPathologyImmunotherapeuticsPharmacotherapy +20

Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells

Min Yang, Bo Ma, Hanshuang Shao, +2

BMC Cancer

Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells

Nikolina Dioufa, Amanda M. Clark, Bo Ma, +2

Molecular Cancer